BELL.L
Belluscura plc [BELL.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BELL.L Stock Summary
In the News
BELL.L Financial details
Company Rating
-
Market Cap
14.85M
Income
-10M
Revenue
1.2M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
24
Optionable
No
Shortable
Yes
Earnings
27 Jun 2024
P/E
-4.68
Forward P/E
-
PEG
-0.61
P/S
33.81
P/B
2.02
P/C
-
P/FCF
-2.37
Quick Ratio
0.67
Current Ratio
4.77
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.08
EPS next Y
-
EPS next Q
-
EPS this Y
45.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
38.39%
Revenue last 5Y
41.6%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-80%
Inst Own
-
Inst Trans
-
ROA
-37%
ROE
-39%
ROC
-0.51%
Gross Margin
5%
Oper. Margin
-744%
Profit Margin
-627%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.65-52.0
52W High
-98.56%
52W Low
-89.29%
RSI
44
Rel Volume
5.03
Avg Volume
403.43K
Volume
2.03M
Perf Week
3.45%
Perf Month
-16.67%
Perf Quarter
-91.67%
Perf Half Y
-91.89%
-
-
-
-
Beta
0.652
-
-
Volatility
0.01%, 0.09%
Prev Close
0%
Price
0.75
Change
0%
Company Profile
- Volume Average 403.43K
- Market Capitalization 14.85M
- Employee 24
- CEO Mr. Robert Rauker
- Headquarters London,GB
- IPO Date 2021-05-28
-
Website
https://www.belluscura.com 
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
